FDA NDC Directory · JSON-LD · Markdown

Irinotecan Hydrochloride

NDC 25021-230 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameirinotecan hydrochloride
Labeler / ManufacturerSagent Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA090675
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsIRINOTECAN HYDROCHLORIDE (20 mg/mL)
Marketing started20140815
Marketing ended20261031
Package count2

External sources

Source: openFDA. Public-domain (CC0).